市場調查報告書
商品編碼
1505174
全球螢光導引手術系統市場 2024-2031Global Fluorescence Guided Surgery System Market 2024-2031 |
螢光導引手術系統市場規模、佔有率和趨勢分析報告,按類型(SPY 系統、PDE 系統和 VS3 銥系統)、手術(開放性手術、腹腔鏡/內視鏡)和應用(癌症手術、心血管手術和其他)預測期(2024-2031)
預計在預測期內(2024-2031 年)螢光導引手術系統市場將以 15.7% 的複合年成長率成長。螢光導引手術 (FGS) 是一種光學成像技術,在手術過程中使用不可見光創建手術區域的即時影像。這有助於外科醫生以更高的精確度和準確度識別、去除或保留腫瘤、癌細胞和神經等解剖特徵。 FGS 還可以降低損傷健康組織的風險,從而縮短手術時間並減少重複手術的需要。
Fluorescence Guided Surgery System Market Size, Share & Trends Analysis Report by Type (SPY System, PDE System, and VS3 Iridium Systems), by Surgery (Open Surgery, and Laparoscopy/Endoscopy), and by Application (Cancer Surgeries, Cardiovascular Surgeries, and Others) Forecast Period (2024-2031)
Fluorescence-guided surgery system market is anticipated to grow at a CAGR of 15.7% during the forecast period (2024-2031). Fluorescence-guided surgery (FGS) is an optical imaging technique that uses invisible light to create a real-time image of the surgical area during a procedure. This helps surgeons identify and remove or preserve anatomical features like tumors, cancer cells, and nerves with greater precision and accuracy. FGS can also reduce the risk of damaging healthy tissue, which can shorten the operation and decrease the need for repeat surgeries.
Market Dynamics
A growing number of surgeries
The number of surgical procedures, healthcare spending, and regulatory approvals are all expected to increase, which will drive growth in the global FGS system market. Improved fluorescent probes that are extremely selective to malignant cells or target tissues are the result of research and development. During operations, these probes help doctors see the surgical site more clearly. Clinical evidence demonstrates that FGS improves patient outcomes, which motivates medical facilities to implement it during surgeries.
A rising number of research and development
Research and development activities result in the creation of ever-more-advanced fluorescent probes that are extremely selective to malignant cells or other target tissues. With the use of these probes, doctors can see the surgical site more clearly while performing their procedures. An expanding clinical data collection shows that FGS has improved patient outcomes. The use of these technologies by healthcare facilities is encouraged by these findings.
Market Segmentation
SPY System is Projected to Emerge as the Largest Segment
The growing prevalence of cardiac problems has led to a dominant market for the SPY system, which employs FGS to enhance surgical outcomes. Similar to the SPY system, FGS systems leverage particular biological targets and real-time tissue perfusion monitoring during surgery. With the SPY system, surgeons can perform procedures with minimal difficulties and improve patient outcomes. Hence, these systems hold a major share in the global market.
The global fluorescence-guided surgery system market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Asia-Pacific countries to serve as a clinical research center
North America Holds Major Market Share
The high prevalence of chronic diseases including cancer and cardiovascular disease, as well as the high level of awareness and demand for sophisticated surgical treatments across the region, are the key contributors to the regional market share. Moreover, the advanced healthcare infrastructure of the region along with favorable medical reimbursement policies regarding surgical procedures are likely to drive the regional market growth.
The major companies serving the global fluorescence-guided surgery system market include Hamamatsu Photonics K.K., Olympus Corp., Stryker Corp., Medtronic PLC, and Getinge AB, among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market.